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Abstract
Background: Staphylococcus pseudintermedius is the leading cause of pyoderma in dogs and the frequent use of
antimicrobial treatment is associated to the development of resistance to nearly all classes of antibiotics. Despite S.
pseudintermedius significance, our understanding of the molecular mechanism of β-lactam resistance and its genetic
diversity remains limited. We aimed to: i) determine the phenotypic resistance profile of methicillin resistant
Staphylococcus pseudintermedius (MRSP) isolated from infected dogs in three different veterinary hospitals in Buenos
Aires, Argentina; ii) identify the SCCmec elements and resistance genes; and iii) analyze the clonal relationship
between isolates and in regard of dominant lineages found in the world.
Results: In addition to the differential levels of β-lactam resistance, MRSP isolates (n = 10) showed resistance to 5–6
families of antibiotics, and were therefore categorized as multidrug-resistant. All the isolates were variant of SCCmec
V homologous to S. aureus; additional SCCmecFinder analysis classified five of the genomes as SCCmec type V
(5C2&5) with mecA (encodes for PBP2a), mecRI and mecI and all the genes closely related to the reference SCCmec
type V S. aureus TSGH17 strain. In the remaining five strains, mecA was present, although other genes associated
with SCCmec V including mecR1 and mecI were missing. PBP2a was inducible in low level resistance strains (MRSP
8151), and constitutively expressed in MRSP 8150, suggesting different mecA regulatory mechanisms. MRSP isolates
showed significant genetic diversity: eight PFGE clonal types and six multilocus-sequence typing (MLST) sequence
types (STs) (339, 649, 919, 920, 921 and 922), including four new STs genetically distinct from STs reported in other
geographic areas. Comparative genomics and phylogenetic analyses of the MRSP showed a correlation between
the genetic content and the phenotypes, and established the genetic relationship between the isolates.
Conclusions: MRSP could be a threat to animal health due to it concerning level of antimicrobial resistance. Our
study highlights genetic and epidemiological aspects of multidrug-resistant MRSP strains from Argentina showing
high degree of correlation between the resistance genes and the phenotype of the isolates and, furthermore, they
appeared evolutionary closer to major worldwide reported ST68 and ST71.
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Background
S. pseudintermedius is an important pathogen in dogs
and cats and is sporadically associated with human
infections [1]. Over the past decade, methicillin resistant
S. pseudintermedius (MRSP) has emerged in different
parts of the world and has become one of the most im-
portant bacterial pathogens in small-animal-veterinary-
medicine [2, 3]. Based on data from the World Health
Organization (WHO) and the United Nations in 2016,
antimicrobial resistance in humans, like in companion
animals, represents a problem for public health.
The β-lactam resistance of MRSP is due to penicillin-
binding protein 2a (PBP2a), a protein encoded by the
methicillin resistant gene mecA. This gene is known to
reside in a mobile genetic element, a staphylococcal
cassette chromosome designated SCCmec that contains
the mec gene complex, mecA and some additional genes,
and the cassette chromosome recombinase (ccr) gene
complex, which is responsible for insertion of the
SCCmec cassette into the core genome. So far as many
as thirteen different structural types of SCCmec have
been described in S. aureus based on the different com-
binations of class of mec complexes according to the
presence/absence of regulatory genes and insertion se-
quences, and ccr allotypes (ccrAB and ccrC) [4]. Eleven
main types, subtypes, and variants have already been
described in the database of the International Working
Group on the Staphylococcal Cassette Chromosome
(IWG-SCC) [5]. Some S. aureus and coagulase-negative
Staphylococcus isolates carry a mecA homolog, mecC,
which has been recently reported carried by SCCmec XI
[6, 7]. The classification of SCCmec elements is com-
plex, given that there are composite cassettes and
pseudo-SCCmec elements that do not harbor ccr
genes [8]. While in S. aureus the structure of SCCmec
elements has been shown to be relatively stable, in
MRSP the SCCmec elements showed high genetic
diversity [4].
The cefoxitin disk is considered as the main method
for methicillin resistance detection in S. aureus, never-
theless this is not an accurate method of screening for
methicillin resistance in S. pseudintermedius [9, 10], that
must be detected with the oxacillin disk.
In Argentina, previous studies have revealed a prevalence
of methicillin resistance between 10 and 30% of S. pseudin-
termedius clinical isolates obtained from dogs [11, 12].
Several dominant MRSP lineages have been identified
in the world, including ST45, ST68 and ST71 [8], but
the molecular epidemiology of MRSP clones circulating
in Argentina has not been examined.
The aims of this study were to determine the pheno-
typic resistance profile of MRSP, to identify the SCCmec
elements and resistance genes, to analyze the clonal
relationship between isolates, and to compare these
isolates with the dominant lineages found globally.
Results
Antibiotic resistance profiles
All the S. pseudintermedius isolates were considered re-
sistant to oxacillin based on the recently revised Clinical
and Laboratory Standards Institute (CLSI) breakpoints
of S. pseudintermedius, the presence of mecA gene and a
SCCmec element. We identified from the total of 10
MRSP strains two distinct groups with different expres-
sion of β-lactam resistance. Six of the ten isolates
displayed low-level of oxacillin resistance with minimal
inhibitory concentration (MIC) values in the range of
0.5 to 2 mg/L despite being mecA positive, and the rest
(4 of 10 isolates) exhibited high-level resistant (≥8 mg/L)
(Table 1). All the strains were resistant to oxacillin,
penicillin, streptomycin and kanamycin. In addition to
the β-lactam resistance gene mecA, all the isolates
contained the β-lactamase gene blaZ, the kanamycin
and neomycin phosphotransferase gene aph (3′)-III and
the streptomycin adenylyl-nucleotidyltransferase gene
ant(6)-Ia. Resistance to macrolides, lincosamides, and
Table 1 Phenotypic and genotypic characteristics of the MRSP strains
OXA oxacillin, FOX cefoxitin, PEN penicillin, ERY erythromycin, CLI clindamycin, TET tetracycline, CMP chloramphenicol, RFA rifampicin, GEN gentamicin, STR
streptomycin, KAN kanamycin, SXT trimethoprim-sulfamethoxazole, NIT nitrofurantoin, LNZ linezolid and CIP ciprofloxacin, S susceptible, R resistant.
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streptogramins-B seen in eight isolates was due to the
methylase gene ermB, and all of them displayed consti-
tutive resistance to clindamycin. The nine trimethoprim/
sulfamethoxazole-resistant isolates contained the dihy-
drofolate reductase gene dfrG, and the three tetracycline
resistant isolates carried the tetracycline and minocycline
resistance gene tetM. Only one strain was resistant to
gentamicin, and it had the aac(6′)-Ie–aph(2′)-Ia gene.
Table 2 summarizes the genes associated with resistance
and the antimicrobial resistance phenotype displayed by
the isolates.
In addition, mutations in the quinolone resistance-
determining region (QRDR) of the topoisomerase
genes of the seven ciprofloxacin-resistant isolates were
found, including amino acid substitution S84 L in the
topoisomerase GyrA and S80I in GrlA. Additional
amino acid substitutions were identified outside the
QRDR of the topoisomerase genes (Table 3), but their
role in fluoroquinolone resistance was not deter-
mined. The isolate MRSP 8472 has only one amino
acid substitution in grlA gene and remained suscep-
tible to ciprofloxacin. No mutations were found in
the gyrB and grlB genes in any of the isolates. All the
isolates were susceptible to chloramphenicol, rifampi-
cin, nitrofurantoin and linezolid. All the MRSP strains
in the present study were resistant to more than
three antimicrobial classes and therefore were classi-
fied as multidrug-resistant (MDR) [13].
Differential levels of PBP2a expression in MRSP correlates
with their β-lactam resistance
Resistance to methicillin in S. pseudintermedius, as well
as in S. aureus is due to the presence of the mecA gene,
which encodes penicillin-binding protein 2a (PBP2a);
this protein shows reduced affinity for all β-lactam anti-
microbials. S. aureus strains that have the mecA gene in-
corporated in the genetic element SCCmec are
considered to be resistant to all β-lactam antimicrobials.
Analysis of PBP2a by Western blot was performed by
using specific anti-PBP2a antibodies in protein lysates of
MRSP strains expressing either high level of oxacillin re-
sistance (MRSP 8150, oxacillin MIC > 256mg/L) or low
(MRSP 8151, oxacillin MIC 2mg/L) grown without and
with sub-inhibitory concentrations of oxacillin and
cephalexin at 0.5μg/ml. As shown in Fig. 1, while PBP2a
was inducible in strains expressing low levels of resist-
ance (i.e MRSP 8151), it appeared to be constitutively
expressed in MRSP 8150, suggesting different regulatory
mechanisms in MRSP. Furthermore, the strain MRSP
8150 has both blaI/blaR1 and mecI/mecR1 genes
unlike MRSP 8151 that only has blaI/blaR1. These
results may indicate that β-lactam expression in
MRSP strains could be linked to mecA differential
regulation.
Characterization of the SCCmec element in MRSP strains
Characterization of the SCCmec cassette was performed
by multiplex PCR showing that all the isolates displayed
the same pattern of bands, but different from the control
isolates SCCmec I to VI. The pattern shared two bands
with the SCCmec type V element corresponding to mecA
and ccr complex, but differed in the band corresponding
to J1 region suggesting that it could be a variant of
SCCmec V (Fig. 2).
Each of the strain genomes was submitted to SCCmec-
Finder [14], an in silico web-based bioinformatic tool
that identifies and types SCCmec elements. Using this,
the SCCmec type V (5C2 and 5) / SCCmec type Vb (5C2
and 5) was identified in five of the genomes, indicating
that there was significant homology with S. aureus
AB512767.1 (TSGH17), which was used as a reference.
Further BLAST analysis between all the genes annotated
in AB512767.1 showed that all the SCCmec V genes
found in the cassette were present on a single contig in
MRSP 8472, while the other isolates that had the genes
on more than one contig. The fastq files from nine iso-
lates were mapped against the MRSP 8472 genome to
see if any reads mapped to these genes, or to other genes
known to be present in the SSCmec cassette. This com-
parison showed that five of the genomes (MRSP isolates
8150, 8468, 8469, 8472 and 8473) have mecA, mecR1
and mecI, and the majority of the genes that are present
in AB512767.1 (Fig. 3). Two of these genomes (MRSP
isolates 8150 and 8472) had all of the genes present in
AB512767.1 and three of them (MRSP 8468, 8469 and
8473) have mecA, mecR1 and mecI, but were missing the
last two genes on the 5′ end. The remaining five ge-
nomes (MRSP 8148, 8151, 8470, 8471 and 8474) have
Table 2 Resistance Genes and Antimicrobial Resistance Phenotypes of the MRSP strains
No. of Isolates Resistance Genes Antimicrobial Resistance Phenotype
5 mecA, blaZ, ermB, dfrG, aph(3`)-III, ant(6)-Ia OXA, PEN, ERY, CLI, STR, KAN, SXT, CIP*
2 mecA, blaZ, tetM, dfrG, aph(3`)-III, ant(6)-Ia OXA, PEN, TET, STR, KAN, SXT
1 mecA, blaZ, ermB, dfrG, aph(3`)-III, ant(6)-Ia, aac(6′)-aph(2″) OXA, PEN, ERY, CLI, GEN, STR, KAN, SXT, CIP*
1 mecA, blaZ, ermB, tetM, dfrG, aph(3`)-III, ant(6)-Ia OXA, PEN, ERY, CLI, TET, STR, KAN, SXT
1 mecA, blaZ, ermB, aph(3`)-III, ant(6)-Ia OXA, PEN, ERY, CLI, STR, KAN, CIP*
* The amino acid substitutions related to the CIP resistance are shown in Table 3
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mecA, but were missing many of the other genes as-
sociated with SCCmec V, including mecR1 and mecI
(Fig. 3). These results suggest that MRSP strains har-
boring mecA are differentiated into two distinct
groups.
Population structure analysis
To identify the relatedness of the MRSP strains PFGE
was performed. We found that the ten MRSP strains
were differentiated in eight clonal types (A to H). More-
over, identical patterns were observed between MRSP
8468 and MRSP 8469 strains (type A) while MRSP 8470
and MRSP 8471 strains displayed type B (Additional file 1:
Figure S1). Additionally, MRSP type characterization
was performed by using MLST as described in Methods.
We found that the MRSP strains were differentiated into
six different STs.
Two of them MRSP 8150 and MRSP 8472 belong to
ST339 while MRSP 8468 and MRSP 8469 were related
to ST649. These ST types have been described and
already included in PubMLST database. The six
remaining isolates had previously undescribed allelic
profiles and were assigned new sequence types by the S.
pseudintermedius MLST database curator. MRSP 8148,
MRSP 8470 and MRSP 8471 belong to ST919, MRSP
8151 to ST920, MRSP 8473 to ST921 and MRSP 8474
to ST922.
To determine the clonal relationship between the STs
detected in this study with those found in the global
Pub-MLST S. pseudintermedius database, all the entries
available on June 2018 were clustered using the same
goeBURST procedure (Fig. 4). The clonal complex (CC)
consisted of allelic profiles with five or more allele
matches, while singletons were unrelated to any other
within the collection. The goeBURST algorithm showed
that three of them (STs 919, 920 and 922) are single
locus variant with each other, two (STs 649 and 921) are
singletons and ST339 is part of a branch located very far
from the other isolates. As shown in Fig. 4, none of
the isolates in Argentina were related to ST68 or
ST71. This data clearly indicates that the MRSP
strains are not identical to ST68 and ST71 but evolu-
tionary related.
Comparative genomics and phylogenetic analyses
Analysis of the MRSP genomes in PATRIC showed an
average size of 2,344.838Mb (range 2.550.634 to
2.650.119), with an average 2779 genes annotated (range
2528 to 2647). The genome composition of MRSP was
found similar between the different genomes analyzed
(Table 4). A phylogenetic tree that included 152 S. pseu-
dintermedius previously sequenced genomes and the 10
strains in this study was generated (data not shown).
Nineteen strains from the representative clades in this tree
were selected for a new tree that included the 10 genomes
(Table 5 and Fig. 5). The phylogenetic analysis shows that
the 10 genomes in this study were not monophyletic, with
MRSP 8472 and MRSP 8473 separated from the other
eight isolates (Fig. 5) that clustered together.
Discussion
S. pseudintermedius is a canine and feline commensal
and opportunistic pathogen, analogous to S. aureus in
Table 3 Amino acid substitutions in the topoisomerase genes
of the 10 MRSP strains
Fig. 1 Western blot analysis of PBP2a protein in lysates of MRSP strains grown without and with subinhibitory concentrations of oxacillin (OXA)
and cephalexin (CFL) at 0.5 μg/ml. Lower image correspond to Ponceau staining used as loading control. Oxacillin (OXA), cephalexin (CFL),
uninduced (Unin)
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humans. MRSP has recently emerged in small animals
worldwide and represents a serious threat to animal
health due to its characteristic multidrug resistance
phenotype [15].
In this study we compared the resistance phenotype
presented by ten clinical strains of MRSP with the geno-
typic analysis including WGS data. The cefoxitin disk
test, which has been shown in several studies to be the
most reliable predictor of the presence of mecA in both
S. aureus and coagulase-negative Staphylococcus, does
not identify MRSP isolates of human and veterinary
origins [9, 10, 16] and would therefore not have been
appropriate for the isolates in this study. Although all
the isolates included in the present study were resistant
to oxacillin using the current CLSI breakpoints, they
could be separated into two groups, with either high or
low oxacillin MICs resistance levels. Western blot ana-
lyses of PBP2a included the strains MRSP 8150 and
MRSP 8151. MRSP 8150 demonstrated a high level of
resistance, which was consistent with constitutive mem-
brane levels of PBP2. The levels of PBP2a in MRSP 8151
were only inducible after exposure to oxacillin or cepha-
lexin. The differential expression of β-lactam resistance
has been observed in MRSA [17]. In previous studies,
Fig. 2 SCCmec characterization of the MRSP strains by multiplex PCR. Lane 1: MW marker 100 bp; lane 2: SCCmec I; lane 3: SCCmec IA; lane 4:
SCCmec II; lane 5: SCCmec III; lane 6: SCCmec IV; lane 7: SCCmec VI; lane 8: SCCmec V; lane 9: MRSP 8148; lane 10: MRSP 8150; lane 11: MRSP 8151
Fig. 3 Comparison of the SCCmec region of the S. aureus TSGH17 (SCCmec V) with the ten isolates of our study. Five of the genomes showed
high homology with the SCCmec V compared to the reference genome (TSGH17). The other five genomes have similar ccr complex and mecA
and ccrC genes, but were missing many of the other genes associated with SCCmec V, including mecR1 and mecI
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we have demonstrated that PBP2a can be co-regulated
by both mecI and blaI regulators [17]. The observation
that blaI/blaR1 regulatory system, present in all the
MRSP strains in this study (Table 3), led us to speculate
that blaI/blaR1 is indispensable to mediate mecA regula-
tion in MRSP. In accordance with this observation,
constitutive levels of PBP2a seen in MRSP 8150 may be
due to defective function of blaI/blaR1 despite the pres-
ence of mecR1/mecI, however this hypothesis awaits ex-
perimental confirmation and further studies are needed
to demonstrate this finding.
In addition to resistance to β-lactams, MRSP isolates
showed resistance to other antibiotics such as aminoglyco-
sides, macrolides, lincosamides, tetracyclines, trimethoprim/
sulfamethoxazole and fluoroquinolones. Based on these
results, all the MRSP that showed resistance to five or six
families of antibiotics, were categorized as MDR.
The genes responsible for the resistance to penicillin,
tetracycline, erythromycin and trimethoprim/sulfameth-
oxazole (blaZ, tetM, ermB and dfrG genes, respectively)
have also been found to be the predominating genes
encoding for resistance in S. pseudintermedius from
dogs in other studies [18, 19]. Resistance to aminoglyco-
sides was associated with the adenyl nucleotidyltransfer-
ase gene ant(6)-Ia and the phosphotransferase gene
aph(3′)-III. The bifunctional acetyltransferase/phospho-
transferase gene aac(6′)-Ie–aph(2′)-Ia was present only
in one gentamicin resistant strain. Comparable results
Fig. 4 Population snapshot of MRSP. goeBURST analysis in which the branches are connected with a single locus variant level to show the
relation of STs. Stars indicate STs from Argentina. ST339 is not shown in the figure
Table 4 Genomic characteristics of the 10 MRSP strains
Strain Genome ID Contigs Genome length (bp) GC content (%) CDS number
MRSP 8148 283.734.711 1 2,617,399 37.54 2528
MRSP 8150 283.734.761 153 2,650,119 37.21 2647
MRSP 8151 283.734.762 171 2,609,428 37.36 2630
MRSP 8468 283.734.763 126 2,584,184 37.32 2533
MRSP 8469 283.734.764 129 2,584,234 37.33 2540
MRSP 8470 283.734.765 142 2,564,903 37.37 2537
MRSP 8471 283.734.766 142 2,550,634 37.42 2544
MRSP 8472 283.734.767 165 2,604,960 37.24 2604
MRSP 8473 283.734.768 164 2,612,019 37.27 2598
MRSP 8474 283.734.769 168 2,621,592 37.41 2636
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were found in a similar study performed in a veterinary
medical teaching hospital in Texas, where the most
common aminoglycoside resistance gene found was
aph(3′)-IIIa, followed by aac(6′)/aph(2′′) and ant(4′)-Ia
genes [20]. Most of the resistance genes detected in S.
pseudintermedius have also been identified in other spe-
cies of staphylococci. Only the seven isolates phenotyp-
ically resistant to fluoroquinolones had mutations in
topoisomerase II (gyrA S84 L) and IV (grlA S80I) simul-
taneously. In a previous study Descloux et al. identified
numerous base pair exchanges in the genes gyrA, gyrB,
grlA and grlB of S. pseudintermedius resistant to fluoro-
quinolones [21]. The same substitutions: S84 L and
E88G in gyrA as well as S80I and D84N in grlA, were
seen in fluorquinolone resistant MRSP isolates from
Japan [22] and two others S84 L and S80R in gyrA
identified in eight ciprofloxacin-resistant MRSP isolates
from Spain [23]. Our results show excellent correlation
between the resistance phenotypes and the resistance
genes detected, similarly to reported recently by other
authors [24].
The information gleaned by full genome sequencing of
staphylococcal species allows to determine the diversity
of SCCmec elements, the structural organization and the
genetic content including genetics variants (e.g. inserts,
deletions) [25]. SCCmec of S. pseudintermedius displayed
some degree of homology to those of S. aureus, but
sometimes they are untypeable using SCCmec typing
schemes developed for S. aureus. The homology between
SCCmec cassettes of different species is considered as an
indication of horizontal gene transfer between isolates.
SCCmec V is largely homologous to SCCmec type V
(5C2&5), previously named VI or VII from S. aureus.
Conversely, SCCmec II-III consists in a combination of
SCCmec II from S. epidermidis and of SCCmec III from
S. aureus and has lacked the cadmium resistance operon,
and SCCmec VII-241 is a newly described element that
is not related to SCCmec VII from S. aureus [26]. The
SCCmec type III variants were found in a study carried
out in a veterinary hospital from Japan, where SCCmec
type II-III represented 85.2% of S. pseudintermedius iso-
lates [27]. In our study, according to the multiplex PCR
method designed by Milheirico et al for S. aureus, all the
isolates appear to be a variant of SCCmec V. SCCmec-
Finder [14] could only classify five genomes as SCCmec
type V(5C2&5)/SCCmec type Vb(5C2&5) due to the
fragmented assemblies of the new isolates. A more
detailed analysis of the genomes allowed us to observe
that these five genomes not only have mecA, mecR1 and
mecI, but also have a majority of the genes that are
present in the isolate used as reference of SCCmec V.
Moreover, two of these genomes had all of the genes
present in the S. aureus TSGH17 that was used as a ref-
erence. The other five isolates have mecA, but were
missing many of the other genes associated with
SCCmec V, including mecR1 and mecI. Further studies
Table 5 Genomes used for phylogenetic analysis in addition to the new isolates from this study
Strain GenBank Accession Genome Length (bp) Contigs Country
E140 ANOI01000000 2769458 1 Denmark
ED99 CP002478 984892 1 United Kingdom
HKU10–03 CP002439 2617381 1 Hong Kong
063228 CP015626 2766566 1 United States
2080722072011 PEOJ01000000 2571729 101 Netherlands
2121129020011 PEPR01000000 2576622 63 Netherlands
2121224012011 PEPS01000000 2650237 98 Netherlands
2130123015011 PEPV01000000 2624816 61 Netherlands
2131211036011 PEQD01000000 2720206 100 Netherlands
41–096 MPKZ01000000 2530792 31 United States
MRSP 651 PHIB01000000 2695563 37 United States
MRSP 742 PHHY01000000 2637262 38 United States
MRSP 424 PRDQ01000000 2660157 43 United States
MRSP 980 PRDR01000000 2634738 45 United States
NA45 CP016072 2841212 1 United States
SL/114 MQND01000000 2590176 51 Sri Lanka
SP79 AP019372 2509706 1 Japan
ST496 1 QEJK01000000 2746304 226 Australia
ST64 2 QEJT01000000 2617379 347 Australia
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are warranted to characterize the SCCmec element
displayed by these isolates, which have the same ccrC re-
combinase but appears to be a different combination of
genes than those described up to now. Although we
observed differences in the SCCmec elements between
the isolates, the differences in oxacillin MICs seem not
to be associated to different SCCmec types, as has been
recently described [8, 28].
The dissemination of MRSP isolates tended to be
associated with a limited number of clones, unlike
methicillin susceptible S. pseudintermedius isolates that
presented great genetic diversity [29], similarly to the
situation observed in human S. aureus. ST68 clone
SCCmec V and ST71 SCCmec II-III are the dominant
clones that have spread in North America since 2003–04
and in Europe since 2005–06, respectively, but now have
a global distribution [30]. A study performed in Brazil
was the first in South America to have detected the
European clone ST71 of MRSP colonizing companion
animals [31]. The isolates of our collection showed
significant genetic variation between the population
manifested by eight clonal types differentiated by PFGE
and six sequence types (STs) by MLST (339, 649, 919,
920, 921 and 922), including four new STs that were
genetically distinct from the previous STs in other
geographic regions. The analysis by goeBURST of our
isolates showed that they were not related to ST68 or
ST71. However, ST68 and ST919 are double locus vari-
ant from ST677, which could indicate that our isolates
are evolutionarily closer to ST68 than ST71. Notably the
diversity of STs shown by our MRSP isolates indicates
high clonal diversity in our country. We found that both
internationally reported as well as previously unreported
MRSP STs are present in Argentina. Giving that the
clones ST919, ST920, ST921 and ST922 had not been
previously reported, it is likely that they represent locally
evolved clones.
Conclusions
In summary, this is the first report addressing the
phenotypic and genotypic characterization of canine
MRSP isolated in Argentina between 2008 and 2011.
Fig. 5 Phylogenetic tree of the ten MRSP isolates and selected representative strains. Phylogenetic tree that includes the ten MRSP isolates of the
present study and a selection of nineteen previously sequenced genomes that were selected among 152 genomes and represent the phylogenetic
diversity found across the species
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The ability of MRSP to acquire and maintain resist-
ance genes, and its propensity for horizontal transfer
of resistance determinants have shown to represent a
potential threat on both the veterinary and Public
Health settings.
Methods
Bacterial strains and identification
Clinical samples were collected from the infected dogs
at three different veterinary hospitals in Buenos Aires,
Argentina between 2008 and 2011. Three strains (MRSP
8148, MRSP 8150 and MRSP 8151) were the only methi-
cillin resistant detected in a previously studied strain
collection of 28 S. pseudintermedius [11]. The other
seven strains were recovered in two laboratories from
Buenos Aires city during 2011 and fully characterized at
the Antimicrobial Division, INEI-ANLIS “Dr. Carlos G.
Malbrán”, Regional Reference Laboratory on Antimicro-
bial Resistance, Buenos Aires, Argentina The ten MRSP
isolates included in the present study were isolated from
infections in different body sites (Table 1). Species iden-
tification was performed by conventional biochemical
tests and confirmed by mass spectrometry MALDI-TOF
(Bruker Daltonics Microflex LT, Billerica MA, USA).
The isolates were pheno- and genotypically character-
ized at the Antimicrobial Division, INEI-ANLIS “Dr.
Carlos G. Malbrán”.
Susceptibility testing of MRSP isolates
S. pseudintermedius strains were tested by disk diffusion
to evaluate their antimicrobial susceptibility to the
following antibiotics (disk concentration in brackets):
oxacillin (1 μg), cefoxitin (30 μg), penicillin (10 units),
erythromycin (15 μg), clindamycin (2 μg), tetracycline
(30 μg), chloramphenicol (30 μg), rifampicin (5 μg), gen-
tamicin (10 μg), streptomycin (10 μg), kanamycin (30 μg),
trimethoprim-sulfamethoxazole (1.25/23.75 μg), nitrofur-
antoin (300 μg), linezolid (30 μg) and ciprofloxacin
(5 μg). Oxacillin MIC was determined by agar dilution in
MH agar + 2% NaCl (CLSI) with a range of antibiotic
concentrations from 0.03 to 8 mg/L, and by Etest
(bioMérieux, France). All antimicrobial susceptibility
tests were carried out according to the CLSI guidelines
[32, 33]. S. pseudintermedius strains were categorized as
susceptible, intermediate, or resistant, when the applic-
able breakpoint was available in CLSI documents
VET01S-3rd ed., 2015 or M100S-27th ed., 2017. Despite
the lack of CLSI-approved interpretative criteria for
streptomycin and kanamycin, the isolates for which the
inhibition zone was 6 mm were considered as resistant.
Isolates were considered as multidrug-resistant when
they exhibited resistance to three or more different
classes of antimicrobial agents [13].
PBP2a analysis in MRSP strains
Western blot analysis was used to determine changes in
PBP2a levels as previously described [34]. Briefly, mem-
brane proteins (15 μg) will be extracted from MRSP
strains growing with/without sub-inhibitory concentra-
tions of oxacillin and cephalexin (CFL) at 0.5 μg/ml in
MHB until mid-exponential phase; cell pellets were re-
suspended in 600 μl of phosphate-buffered saline (PBS),
disrupted by adding glass beads and using a FastPrep cell
disrupter (MP Biomedicals, Santa Ana, CA, USA); the
lysate was centrifuged at 8,000×g for 10 min at 4 °C. The
supernatant fraction was centrifuged for an additional 5
min at 8,000×g at 4 °C to remove the beads, and the
supernatant transferred to ultracentrifuge tubes and
ultracentrifuged at 45,000 rpm for 1 h/4 °C. The mem-
brane pellet was resuspended in PBS, total membrane
proteins quantified and stored at − 80 °C. Lysates were
separated on 4 to 12% bis-Tris gels, blot transferred onto
pure nitrocellulose blotting membranes, and after block-
ing (5% low-fat milk in PBS), PBP2a was probed with
monoclonal anti-PBP2a antibody (Slidex MRSA detec-
tion kit; bioMérieux, France).
Genotyping
mecA gene PCR
All the MRSP strains were tested for the presence of the
mecA gene by PCR. PCRs were performed as previously
described [35], S. aureus ATCC 43300 and S. aureus
ATCC 29213 were used as positive and negative control,
respectively.
Identification of SCCmec elements among MRSP strains
MRSP isolates were first screened for typical SCCmec
elements by multiplex PCR as previously described [36].
S. aureus collection strains were used as control of each
SSCmec type: COL, PER34, BK2464, USA100, ANS46,
HU25, USA400, a clinical strain and HDE288 were used
as positive control of SCCmec types I, IA, II, III, IV, V
and VI respectively [36]. The genome sequence from
each of the 10 new isolates was examined in the
SSCmecFinder resource [14] to determine the SSCmec
type. In addition, the SSCmec V (GenBank Id AY894416)
[37] nucleotide and individual protein sequences were
compared by BLAST [38] to the new genomes in PATRIC
[39]. A careful examination of the region containing the
SCCmec V genes and its flanking regions was conducted
using the Proteome Comparison and Compare Region
View [40] tools found in PATRIC. A broad examination
for the presence or absence of the protein families that
contain mecA, mecR1 and mecI genes across all S. pseu-
dintermedius genomes was conducted using PATRIC’s
Protein Family Sorter [41].
As the MRSP 8472 genome had all the genes in the
SSCmec element present on a single contig, the reads
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from the remaining nine genomes were mapped to that
genome using PATRIC’s variation service to confirm the
presence or absence of the genes in the SCCmec V re-
gion. Genes were considered present when reads were
present that overlapped both the 5′ and 3′ ends of the
genes in MRSP 8472, as well as covering more than 60%
of the total length of the gene.
Pulsed-field gel electrophoresis (PFGE) analysis
Chromosomal DNA of the MRSP strains digested with
Smal was analyzed by PFGE, as described previously
[42]. PFGE was carried out by clamped homogeneous
electric field electrophoresis with a CHEF DR III System
(Bio-Rad Laboratories, Richmond, CA, USA). PFGE was
performed under the following conditions: switch time,
2.0 to 20.0 s and run time, 20 h; temperature 11.3 °C,
angle 120° and voltage 6 V/cm. Separated DNA frag-
ments were stained with ethidium bromide and visual-
ized with a UV transilluminator. Banding patterns were
evaluated by visual inspection and interpreted according
to Tenover criteria [43]. Isolates were considered
unrelated when the PFGE patterns differed in seven or
more bands, consistent with three or more independent
genetic events.
Genome sequencing
Genomic DNA was extracted by using DNeasy Blood
and Tissue Kit (QIAGEN, Valencia, CA, USA) as per
manufacturer’s instructions; concentration was measured
by QubitTM assay (Invitrogen, Carlsbad, CA, USA).
Illumina library preparation was carried out by Nextera
XT DNA Library Preparation Kit (Illumina, San Diego,
CA, USA). Hi-seq sequencing was carried out in our
affiliated Weill Cornell University (New York, NY, USA)
institution at the Epigenetics and Genomic Laboratory,
using an Illumina HiSeq 2000. Assembly, annotation and
analysis of genomes were done through the PATRIC
software (https://www.patricbrc.org). The detection of
resistance genes was carried out with PATRIC using the
available ResFinder (genomicepidemilogy.org) and
CARD (Comprehensive Antimicrobial Resistance Data-
base, card.macmaster.ca) databases, the gene content
were compared with the phenotype presented by them.
Population structure analysis
Sequence types were determined using MLST software
(https://bio.tools/mlst). Sequence types were assigned by
comparison with the allele sequences present in the
PubMLST database (http://pubmlst.org/spseudinterme-
dius) and isolates with a novel combination of alleles
were submitted to the MLST database curator Vincent
Perreten (vincent.perreten@vetsuisse.vbi.unibe.ch). We
determine the clonal relationships of the sequence types
obtained in this study with entries in the global
PubMLST S. pseudintermedius database. All entries
available at the time of analysis were clustered using the
same goeBURST procedure database (http://www.phylo-
viz.net/goeburst/).
Phylogenetic trees
An initial tree including 152 S. pseudintermedius ge-
nomes, including the 10 isolates sequenced in this study,
was created to select appropriate genomes to represent
the phylogenetic diversity found across the species.
Genomes were selected based on clusters identified in
this tree, and as a result, nineteen previously sequenced
genomes representing these branches were selected to
be compared with the 10 Argentinian genomes.
Protein families from genes that were present as a sin-
gle copy per genome were selected, and 1000 of these
Global protein families (PGFams) [44] were used. Both
the protein (amino acid) and gene (nucleotide) se-
quences were used for each of the selected genes.
Protein sequences were aligned using MUSCLE [45],
and the nucleotide coding gene for each was aligned
using the Codon_align function of BioPython [46]. A
concatenated alignment of all proteins and nucloetides
were written to a phylip formatted file, and then a parti-
tions file for RaxML [47] was generated, describing the
alignment in terms of the proteins and then the first,
second and third codon positions. Support values were
generated using 100 rounds of the “Rapid” bootstrapping
option [48] of RaxML. The resulting newick file was
viewed in FigTree [49].
Additional file
Additional file 1: Figure S1. PFGE of 10 MRSP strains digested with
SmaI. Lane 1: MW marker; lane 2: MRSP 8148; lane 3: MRSP 8150; lane 4:
MRSP 8151; lane 5: MRSP 8468; lane 6: MRSP 8469; lane 7: MRSP 8470;
lane 8: MRSP 8471; lane 9: MRSP 8472; lane 10: MRSP 8473; lane 11: MRSP
8474. (TIF 463 kb)
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